Intercept Pharmaceuticals Inc. announces updates to Ocaliva prescribing information for primary biliary cholangitis
Intercept Pharmaceuticals, Inc. announced that the Ocaliva (obeticholic acid or OCA) Prescribing Information in the United States has been updated.The changes to the Ocaliva Prescribing Information were prompted… read more.
